News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Slideshows|November 7, 2019

Zen and the Art of Documentation

Author(s)James L. Knoll IV, MD, Jarrod Marks, MD

Lawyers tend to be good at spotting unexplained inconsistencies in documentation. Take these steps to protect yourself.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Latest CME

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Trending on Psychiatric Times

Beyond Compliance: A Patient-Centered Approach to Psychopharmacological Adherence

EMP-01 for Social Anxiety Disorder Demonstrates Meaningful Improvements in Phase 2a Study

Rational Off-Label Prescribing: A Review With Joseph F. Goldberg, MD, and Henry Nasrallah, MD

Psychedelics Deserve Real Science

A Review of Data on AXS-05 for Alzheimer Disease Agitation in Advance of Next Week's PDUFA Date